{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:00:38Z","timestamp":1791046838551,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1053\/j.gastro.2011.02.010","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T15:51:32Z","timestamp":1297785092000},"page":"1472-1480","source":"Crossref","is-referenced-by-count":41,"title":["Comparability of Probable and Definite Autoimmune Hepatitis by International Diagnostic Scoring Criteria"],"prefix":"10.1053","volume":"140","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2011.02.010_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2011.02.010_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib4","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Practice Guidelines of the American Association for the Study of Liver Diseases","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2011.02.010_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2011.02.010_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2011.02.010_bib11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MCG.0b013e318154af74","article-title":"Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis","volume":"42","author":"Luth","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2011.02.010_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0016-5085(83)90030-6","article-title":"Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology","volume":"85","author":"Czaja","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","article-title":"Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features","volume":"80","author":"Czaja","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","article-title":"Autoantibodies in liver disease","volume":"120","author":"Czaja","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2011.02.010_bib16","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/BF02235164","article-title":"Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy","volume":"16","author":"Soloway","year":"1971","journal-title":"Am J Dig Dis"},{"key":"10.1053\/j.gastro.2011.02.010_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2002-35706","article-title":"Treatment of autoimmune hepatitis","volume":"22","author":"Czaja","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2011.02.010_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2011.02.010_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2011.02.010_bib21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib22","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib25","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","article-title":"The nature and prognosis of severe cryptogenic chronic active hepatitis","volume":"104","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib26","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis","volume":"52","author":"Gassert","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2011.02.010_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1109146","article-title":"Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology","volume":"47","author":"Heringlake","year":"2009","journal-title":"Z Gastroenterol"},{"key":"10.1053\/j.gastro.2011.02.010_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2011.02.010_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib30","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2011.02.010_bib31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","article-title":"Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis","volume":"21","author":"Nezu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2011.02.010_bib33","first-page":"221","article-title":"Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study","volume":"55","author":"Mishima","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.gastro.2011.02.010_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib35","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.23577","article-title":"Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method","volume":"51","author":"Rockey","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2011.02.010_bib36","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.2527\/jas.2006-449","article-title":"Statistical power calculations","volume":"85","author":"Lenth","year":"2007","journal-title":"J Anim Sci"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508511001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508511001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T04:16:33Z","timestamp":1712204193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508511001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0016508511001478"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2011.02.010","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}